IL37 and thyroid cancer: To validate the role of IL–23, miR–25 and SOCS4 in thyroid cancer, the expression of IL–23, miR–25 and SOCS4 were analyzed in 35 pairs of clinical PTC, 26 pairs of clinical FTC, and 22 normal thyroid samples.